AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif. , Aug. 13, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that industry leaders from AbbVie, Astellas, Eikon Therapeutics, Merck & Co.
, Moderna, and Roche will keynote at the upcoming 2024 Veeva R&D and Quality Summit in Boston on Sept. 9-10 . Professionals across life sciences will come together to discuss how connected systems across clinical, regulatory, safety, and quality can move the industry forward for the benefit of patients.
Veeva R&D and Quality Summit is one of the largest life sciences events, drawing more than 2,000 executives to network and learn across more than 100 sessions. Veeva CEO Peter Gassner headlines the opening keynote, sharing innovations and examples of how connected data and systems can significantly streamline drug development and accelerate product time to market. Additional featured keynotes and sessions include: "Veeva is committed to customer success, delivering integrated software, data, and services that can advance innovation for patients in need," said Jim Reilly , vice president of Veeva Development Cloud strategy.
"Veeva R&D and Quality Summit brings the industry together to share learnings, fresh ideas, and new strategies to improve collaboration and accelerate the delivery of novel products." The event is open exclusively to life sciences professionals. Register and stay up to date on the agenda at v.